Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789396 · ClinicalTrials.gov registry record
Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 572
- Enrollment target
NCT03789396 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 572 participants.
The verdict
NCT03789396 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 572 participants
- Enrollment target
Study Summary
The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.
Interventions
- OTHER Targeted Normoxia (oxygen saturation 90-96%)
- OTHER Usual Care Oxygenation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 572 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03789396
The ClinicalTrials.gov registry entry for NCT03789396 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 572 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Targeted Normoxia (oxygen saturation 90-96%) is the first listed.
NCT03789396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03789396 about?
NCT03789396 is a clinical study titled "Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients". The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.
What is the current status of trial NCT03789396?
This trial is currently completed. The enrollment target is 572 participants. The study started on 2018-01-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT03789396?
The interventions under investigation include: Targeted Normoxia (oxygen saturation 90-96%) (OTHER), Usual Care Oxygenation (OTHER).
Who is sponsoring clinical trial NCT03789396?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.